A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology

This publication has 54 references indexed in Scilit:

• Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
  Cancer Cell, 2013
• In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential
  Journal of Cellular Biochemistry, 2009
• Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain ofSalmonella typhymurium
  Cell Cycle, 2009
• Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
  Natural Product Reports, 2009
• Target for cancer therapy: proliferating cells or stem cells
  Leukemia, 2005
• Teratogens as Anticancer Drugs
  Cell Cycle, 2005
• Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma
  Cancer, 2003
• Osteosarcoma of the limb
  The Journal of Bone and Joint Surgery. British volume, 2002
• Neoadjuvant chemotherapy for osteosarcoma of the extremity
  European Journal of Cancer, 2001
• A new patient‐like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice
  International Journal of Cancer, 1992